Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BYFrontiers in drug safety and regulation

Faso Food and Drug Administration (Faso FDA): strengthening regulatory systems for public health protection in Burkina Faso.

  • Kampadilemba Ouoba1
  • Priscilla P M Nyambayo2
  • Daniel Dori1
  • Adela Ashie3
  • Kenneth Onu4
  • Rasmané Semdé1
4 affiliations
  1. 1Laboratory of Drug Development, Joseph KI-ZERBO University, Ouagadougou, Burkina Faso.
  2. 2Pharmacovigilance and Clinical Trials Division, Medicines Control Authority of Zimbabwe, Harare, Zimbabwe.
  3. 3Food and Drugs Authority, Accra, Ghana.
  4. 4African Union Development Agency-NEPAD (AUDA-NEPAD), Johannesburg, South Africa.
Read full textPDFDOICite

Abstract

In May 2026, the Government of Burkina Faso established Faso Food and Drug Administration (Faso FDA) by Decree No. 2026-0602/PF/PRIM/MEF/MS. This unified regulatory authority mandated to oversee food products, health commodities, industrial chemicals, cosmetics, pesticides, and other products with potential public health risks. Endowed with legal personality and administrative and financial autonomy, the Agency should operate independently and mitigate risks related to corruption and conflicts of interest. Its scope aligns with that of other African national regulatory authorities such as the Ghana Food and Drugs Authority and the Rwanda Food and Drugs Authority. The legal establishment of Faso FDA is only the first step and to fully deliver on its mandate, this young regulatory authority must address six strategic priorities: securing sustainable domestic financing; strengthening governance systems and transparency; ensuring adequate infrastructure and technical capacity; developing a competent and sufficient workforce; achieving World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 3; and bolstering regional and international collaboration. Addressing these priorities will position Faso FDA as a robust regulatory authority capable of safeguarding public health and promoting sustainable local production of safe, high-quality food and medical products.

Related

  1. Bioeconomic analysis of ecological intensification innovations in agropastoral systems in western Burkina Faso
    Mahamoudou Koutou, Bruno Barbier, Kalifa Coulibaly +3
    Science et technique - Lettres, Sciences sociales et humainesPeer-reviewedPublisher termsFull textGeneral biologyHAL
  2. Counting what goes uncounted: strengthening measurement of financial protection in health after the 2025 revision of SDG indicator 3.8.2, with evidence from India
    Shyamkumar Sriram
    Frontiers in Health ServicesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  3. Strengthening breastfeeding protection through micro-credential education based on NetCode findings
    M Zemanová, L Micikova, B Vaverkova +7
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
  4. Health Administration, Regulatory Governance, and Clinical Operations Research Compendium: Privacy Compliance, Revenue Cycle Integrity, and Workforce Optimization
    Robert Hicks
    ZenodoPreprintCC BY 4.0Full textZenodo
  5. Chronic {triangleup}9-Tetrahydrocannabinol Vapor Self-Administration Modulates Gut Microbiota and the Immune and Endocannabinoid Systems in Female Sprague-Dawley Rats
    J. J. Rosado-Franco, A. Ellison, E. M. Weerts +2
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{ouoba2026faso,
  title = {{Faso Food and Drug Administration (Faso FDA): strengthening regulatory systems for public health protection in Burkina Faso.}},
  author = {Kampadilemba Ouoba and Priscilla P M Nyambayo and Daniel Dori and Adela Ashie and Kenneth Onu and Rasmané Semdé},
  journal = {Frontiers in drug safety and regulation},
  year = {2026},
  month = oct,
  doi = {10.3389/fdsfr.2026.1880709},
  url = {https://europepmc.org/article/MED/42953202},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Faso Food and Drug Administration (Faso FDA): strengthening regulatory systems for public health protection in Burkina Faso.
AU  - Kampadilemba Ouoba
AU  - Priscilla P M Nyambayo
AU  - Daniel Dori
AU  - Adela Ashie
AU  - Kenneth Onu
AU  - Rasmané Semdé
PY  - 2026
DA  - 2026/10/14
JO  - Frontiers in drug safety and regulation
DO  - 10.3389/fdsfr.2026.1880709
UR  - https://europepmc.org/article/MED/42953202
AB  - In May 2026, the Government of Burkina Faso established Faso Food and Drug Administration (Faso FDA) by Decree No. 2026-0602/PF/PRIM/MEF/MS. This unified regulatory authority mandated to oversee food products, health commodities, industrial chemicals, cosmetics, pesticides, and other products with potential public health risks. Endowed with legal personality and administrative and financial autonomy, the Agency should operate independently and mitigate risks related to corruption and conflicts of interest. Its scope aligns with that of other African national regulatory authorities such as the Ghana Food and Drugs Authority and the Rwanda Food and Drugs Authority. The legal establishment of Faso FDA is only the first step and to fully deliver on its mandate, this young regulatory authority must address six strategic priorities: securing sustainable domestic financing; strengthening governance systems and transparency; ensuring adequate infrastructure and technical capacity; developing a competent and sufficient workforce; achieving World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 3; and bolstering regional and international collaboration. Addressing these priorities will position Faso FDA as a robust regulatory authority capable of safeguarding public health and promoting sustainable local production of safe, high-quality food and medical products.
SN  - 2674-0869
ER  -